ロード中...
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
The only formula of dacarbazine (Dac) in clinical use is intravenous infusion, presenting a poor therapeutic profile due to the low dispersity of the drug in aqueous solution. To overcome this, a nanostructured lipid carrier (NLC) consisting of glyceryl palmitostearate and isopropyl myristate was de...
保存先:
| 出版年: | J Vis Exp |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MyJove Corporation
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4942000/ https://ncbi.nlm.nih.gov/pubmed/27168058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3791/53760 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|